| Patent application number | Description | Published |
|---|
| 20080214531 | Methods and compositions for the treatment of insulin resistance, diabetes, and diabetes-associated dyslipdemia - Methods for the treatment of insulin resistance, diabetes, and/or diabetes associated dyslipidemia by administering niacin and meloxicam are disclosed. | 09-04-2008 |
| 20080275049 | Methods and Compositions for Upregulation of GATA Activity - A novel method of identifying compounds capable of upregulating GATA activity is disclosed. The method includes providing a sample of cells that express GATA, providing a sample of a candidate compound, contacting the cell sample and the compound sample, and measuring a quantitative indicator of GATA activity within the cell sample after the contacting step. GATA inducers identified by the method and uses therefore to upregulate GATA activity in subjects and to prevent or treat atherosclerosis or diabetes in subjects are also described. | 11-06-2008 |
| 20100144722 | NOVEL HETEROCYCLIC COMPOUNDS AS GATA MODULATORS - Novel heterocyclic compounds, sstereoisomers thereof and/or pharmaceutically acceptable salts of formula (I) and its stereoisomers are provided. Additionally, methods of forming novel heterocyclic compounds, stereoisomers thereof and/or pharmaceutically acceptable salts of formula (I) and its stereoisomers are provided. | 06-10-2010 |
| 20100144731 | Novel Biccyclic Compounds As GATA Modulators - Novel bicyclic compounds, stereoisomers, and/or pharmaceutically acceptable salts of the novel bicyclic compounds, and/or pharmaceutically acceptable salts of the stereoisomers of the novel bicyclic compounds are provided. Additionally, methods of forming novel bicyclic compounds, stereoisomers, and/or pharmaceutically acceptable salts of the novel bicyclic compounds, and/or pharmaceutically acceptable salts of the stereoisomers of the novel bicyclic compounds are provided. | 06-10-2010 |
| 20120064161 | MODIFIED RELEASE NIACIN PHARMACEUTICAL FORMULATIONS - Pharmaceutical formulations comprising niacin in a matrix comprising a hydrophobic polymer that modifies release of niacin. | 03-15-2012 |
| 20120071528 | METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA - The invention is directed to novel compounds of Formula I: | 03-22-2012 |
| Patent application number | Description | Published |
|---|
| 20100225091 | AUTOMATIC COUPLING DEVICE - A device for coupling a vehicle to a trailer is provided. The device includes a base having a channel and a pair of sidewalls. The channel includes a mouth leading into a stop. The sidewalls are spaced apart from each other and the channel runs generally between the sidewalls. A catch is pivotally mounted between the sidewalls. The catch includes a mounting end, a catch end, and a contact surface. The catch end is pivotable between a first position, wherein the catch end abuts against the base; and a second position wherein the catch end is displaced from the base. The tow pin engages the contact surface of the catch and pivots the catch end towards the second position. The catch end returns to the first position so as to secure the tow pin between the catch end and the stop when the tow pin abuts against the stop. | 09-09-2010 |
| 20100253474 | DEVICE FOR INCREMENTALLY ADJUSTING THE POSITION OF AN RFID TAG - A device for incrementally adjusting the position of an RFID tag includes a base, and a lid releasably attachable to said base. The base includes a generally planar surface in which a plurality of locators are formed at regular intervals. A portion of the RFID tag is received by one of the plurality of locators, thereby allowing for the incrementally adjustment of the position of the RFID tag. The plurality of locators extend collinearly and are formed overlapping so that the position of the RFID tag is adjustable in increments less than the overall length of the RFID tag. | 10-07-2010 |
| 20120065762 | Methods For Selecting Transportation Parameters For A Manufacturing Facility - Methods for selecting transportation parameters for transporting parts from at least one point of part supply to at least one point of part demand in a manufacturing facility include determining a physical relationship between the at least one point of part supply and the at least one point of part demand, selecting a transportation route type from a preselected group of transportation route types based at least in part on the physical relationship, selecting an automated guided carrier type from a preselected group of automated guided carrier types based at least in part on the transportation route type, determining a need for traffic control based at least in part on the transportation route type, and if it is determined traffic control is needed, selecting a traffic control type from a preselected group of traffic control types based at least in part on the transportation route type. | 03-15-2012 |
